base
indic
cell
intern
cystatin
could
physiolog
pathway
thu
might
import
process
inhibit
viru
replic
tumour
growth
address
question
whether
cystatin
c
uptak
human
cell
initi
chose
cell
line
differ
characterist
human
epidermoid
carcinoma
cell
line
human
mammari
tumour
cell
line
order
allow
us
delin
potenti
uptak
mechan
also
select
two
mammari
cancer
cell
line
accord
american
type
cultur
collect
atcc
express
differ
cell
surfac
receptor
final
ad
anoth
type
cell
human
pancrea
adenocarcinoma
initi
experi
carri
addit
cell
cultur
variou
concentr
cystatin
c
data
shown
studi
cystatin
c
use
within
physiolog
concentr
rang
differ
human
bodi
fluid
follow
incub
cystatin
c
cell
detach
bottom
well
trypsin
also
meant
label
protein
attach
cell
surfac
cleav
could
wash
away
flow
cytometri
use
fluorophor
protein
label
use
experi
result
scattergram
show
domin
easili
defin
group
cell
could
gate
fig
typic
event
exclud
reproduc
experi
high
intern
label
protein
could
demonstr
easili
fig
five
human
cancer
cell
line
intern
cystatin
c
fig
incub
use
ensur
wash
condit
suffici
demonstr
cystatin
bound
cell
surfac
cleav
trypsin
wash
away
min
increas
cell
line
could
detect
min
cell
fluoresc
increas
five
strain
pattern
intern
less
equal
five
strain
two
unrel
protein
act
protein
inhibitor
potato
carboxypeptidas
inhibitor
pci
kda
equistatin
kda
studi
comparison
compar
cystatin
c
low
level
uptak
molecul
detect
differ
cell
line
investig
whether
intern
cystatin
c
activ
process
similar
experi
carri
none
three
cell
line
test
show
uptak
label
cystatin
c
condit
fig
microscop
analys
use
qualit
visual
therebi
confirm
cystatin
c
intern
situ
cell
select
initi
show
neglig
incub
h
cystatin
c
principl
cell
possess
detect
cystatin
c
label
confoc
laser
scan
microscopi
clsm
analys
demonstr
cystatin
c
present
within
cell
cell
bodi
process
detect
plasma
membran
larg
number
cell
fig
show
widespread
cystatin
c
fluoresc
cytoplasm
although
fewer
also
contain
larger
fluoresc
accumul
cell
similar
intracellular
local
cystatin
c
detect
cell
expos
unlabel
cystatin
c
follow
immunolabel
cystatin
c
endogen
intern
use
primari
antibodi
cystatin
c
secondari
antibodi
conjug
fluorophor
fig
fluoresc
label
control
cell
cell
use
antibodi
specif
test
see
experiment
procedur
descript
control
experi
live
imag
experi
clearli
show
uptak
within
min
cystatin
c
structur
stain
lysotrack
fig
cystatin
c
quantifi
normal
cell
cultur
condit
obtain
refer
level
product
distribut
cell
studi
grown
condit
use
intern
experi
cell
incub
h
secret
cystatin
c
medium
cell
extract
repres
intracellular
cystatin
c
quantifi
elisa
intracellular
cystatin
c
level
chang
h
fig
impli
level
ng
cystatin
cell
within
cell
contrast
cystatin
c
concentr
medium
increas
ng
cystatin
cell
fig
expect
protein
secret
result
cellular
product
cystatin
c
cellular
level
cystatin
c
incub
cell
medium
contain
cystatin
c
manner
h
measur
concentr
chosen
within
physiolog
rang
cerebrospin
fluid
semin
plasma
experi
clearli
show
cystatin
c
content
cell
increas
rapidli
first
min
continu
accumul
least
h
final
experi
fig
repeat
experi
show
h
cystatin
c
level
increas
four
six
time
baselin
level
shown
elisa
plateau
note
increas
cystatin
c
longer
incub
time
like
due
increas
competit
cystatin
protein
ie
target
cystein
proteas
extract
concentr
cystatin
c
approach
equilibrium
constant
enzym
bind
affect
cystatin
antibodi
use
assay
lead
underestim
real
intracellular
cystatin
c
concentr
western
blot
use
ensur
fluoresc
seen
confoc
experi
cystatin
c
molecul
measur
elisa
variou
incub
time
repres
intact
cystatin
c
molecul
result
clearli
show
increas
cellular
cystatin
c
content
molecul
intact
judg
mainten
molecular
mass
fig
degrad
product
note
order
estim
cystatin
c
uptak
western
blot
scan
band
repres
cystatin
c
densitometri
fig
result
good
agreement
elisa
experi
shorter
incub
time
clearli
higher
longer
incub
time
support
conclus
quantit
elisa
result
underestim
increas
cystatin
c
continu
throughout
h
incub
also
good
agreement
flow
cytometri
result
fig
evalu
balanc
cystein
proteas
inhibitor
carri
measur
cystein
proteas
inhibitori
capac
extract
cell
incub
cystatin
medium
order
determin
concentr
activ
papain
use
assay
fix
amount
enzym
incub
variou
concentr
titrat
curv
drawn
amount
activ
papain
calcul
baselin
cystein
proteas
inhibitori
capac
cell
lysat
approxim
analys
variou
volum
extract
cell
incub
h
naclpi
ie
cell
expos
cystatin
c
experi
extract
boil
denatur
proteas
abolish
activ
procedur
affect
cystatin
withstand
high
temperatur
without
lose
inhibitori
activ
show
concentr
pmol
cystein
proteas
elucid
whether
total
cystein
proteas
inhibitori
capac
chang
expos
cell
cystatin
c
cell
incub
h
cystatin
c
cystein
proteas
inhibitor
concentr
cell
extract
estim
papain
titrat
indic
substanti
increas
caus
uptak
cystatin
c
affect
total
cystein
proteas
inhibitori
capac
mainli
due
cytoplasm
cystatin
b
within
cell
quantifi
statist
test
increas
intracellular
cystein
proteas
inhibitori
activ
due
cystatin
c
intern
experi
repeat
optim
lysat
volum
accord
titrat
curv
inhibitori
capac
cystatin
cell
cell
compar
result
show
significantli
higher
inhibitori
activ
cell
expos
cystatin
c
compar
control
cell
papain
cathepsin
b
analys
enzym
activ
decreas
respect
fig
context
papain
use
resembl
cathepsin
l
proteas
involv
propag
cancer
order
address
uptak
mechan
cell
incub
label
cystatin
c
preincub
variou
concentr
unlabel
inhibitor
uptak
cystatin
c
decreas
substanti
concentr
unlabel
inhibitor
increas
fig
indic
activ
specif
pathway
cystatin
c
intern
learn
structur
requir
uptak
studi
use
two
cystatin
c
variant
produc
use
mutagenesi
one
variant
c
essenti
lack
abil
inhibit
famili
cystein
proteas
like
papain
cathepsin
b
remov
side
chain
involv
interact
enzym
c
lack
inhibitori
activ
famili
cystein
proteas
legumain
remov
key
amino
acid
site
cystatin
c
amino
acid
substitut
resid
oppos
part
cystatin
c
molecul
make
protein
variant
interest
experi
carri
cell
human
pancrea
adenocarcinoma
use
label
cystatin
c
variant
variant
inhibitor
intern
fig
thu
experi
provid
evid
possibl
target
proteas
involv
uptak
process
indic
site
overlap
site
promot
intern
cystatin
c
experi
demonstr
inhibit
viru
replic
ad
cystein
proteas
inhibitor
cell
medium
led
propos
inhibitor
intracellular
fate
issu
merit
interest
chang
proteas
activ
might
import
cancer
cell
growth
metastasi
angiogenesi
clear
howev
extent
implic
proteas
function
extracellularli
recent
also
propos
cystatin
c
capac
promot
astrogenesi
suppress
oligodendrogenesi
function
seem
independ
cystein
proteas
inhibitor
activ
thu
clear
cystatin
c
variou
effect
cell
seem
independ
cystein
proteas
inhibitori
activ
might
associ
intracellular
activ
nevertheless
specif
cystatin
pathway
implic
cellular
uptak
activ
intern
extracellularli
locat
cystatin
delin
demonstr
cystatin
c
intern
five
differ
cancer
cell
line
use
conceptu
differ
techniqu
clsm
flow
cytometri
western
blot
quantif
intern
inhibitor
immunolog
method
measur
cystein
inhibitori
capac
cell
human
cancer
cell
line
chosen
includ
one
epidermoid
carcinoma
cell
line
three
mammari
tumour
cell
line
one
human
pancrea
adenocarcinoma
five
cell
line
exhibit
cystatin
c
intern
expos
extracellular
cystatin
c
experi
uptak
could
detect
min
case
could
seen
min
uptak
curv
similar
cell
strain
studi
show
cell
exhibit
fluoresc
h
exposur
cystatin
c
addit
flow
cytometri
record
uptak
specif
label
protein
one
specif
cell
strain
highli
reproduc
within
well
run
howev
fluorometr
method
use
measur
degre
protein
label
precis
although
provid
good
estim
detail
comparison
quantiti
uptak
therefor
conclud
lack
uptak
experi
carri
well
competit
experi
support
idea
intern
activ
process
passiv
flow
molecul
cell
thu
suggest
uptak
flow
cytometri
elisa
result
clearli
show
rel
rapid
cystatin
c
uptak
first
minut
increas
appear
much
slower
measur
elisa
monitor
flow
cytometri
therefor
use
western
blot
verifi
intern
cystatin
c
western
blot
develop
cystatin
antibodi
scan
band
repres
cystatin
c
densitometri
result
agre
well
flow
cytometri
data
suggest
linear
uptak
rate
rel
long
period
fig
microscop
analysi
test
cell
line
show
differ
pattern
intern
intracellular
distribut
cystatin
c
cell
line
clsm
demonstr
intern
cystatin
c
distribut
part
cytoplasm
visual
smaller
larger
accumul
addit
clsm
analys
indic
cell
contain
rel
high
level
cystatin
c
appear
local
discret
cellular
compart
lysotrack
thu
indic
local
acid
compart
lysosom
differ
cell
type
also
observ
amount
cystatin
c
uptak
andor
intracellular
local
heterogen
cell
morpholog
shown
microscopi
support
subpopul
cell
possess
differ
abil
cystatin
c
uptak
inhibit
capac
lysat
cell
incub
h
without
label
cystatin
c
show
level
pmol
cystein
proteas
compar
pmol
cystatin
cell
measur
use
elisa
suggest
cystatin
c
constitut
total
cystein
proteas
inhibitor
capac
cell
grown
medium
reason
cystatin
b
domin
intracellular
cytoplasmat
cystein
proteas
inhibitor
h
exposur
cystatin
c
total
cystein
proteas
inhibitor
capac
well
cystatin
c
concentr
cell
increas
indic
experi
uptak
measur
elisa
cystatin
c
level
increas
least
fivefold
fig
thu
intern
cystatin
c
appear
influenc
balanc
proteas
inhibitor
cancer
metastasi
growth
particularli
consid
effici
cathepsin
b
inhibitor
cystatin
b
possibl
intracellular
increas
inhibitori
capac
even
greater
impact
balanc
suspect
first
cystatin
molecul
respons
increas
probabl
local
henc
concentr
cell
compart
eg
endosom
addit
experi
cell
incub
two
cystatin
c
variant
fig
carri
inactiv
substitut
key
amino
acid
side
chain
import
target
enzym
bind
c
c
protein
variant
essenti
deplet
inhibitori
capac
cathepsin
b
enzym
legumain
respect
substanti
intern
suggest
uptak
mechan
depend
residu
central
inhibitori
capac
cystatin
c
experi
carri
cell
line
eman
tumour
differ
origin
behav
ident
regard
cellular
cystatin
c
uptak
seem
possibl
intern
also
seen
normal
cell
ie
gener
physiolog
phenomenon
investig
conclus
use
cell
cultur
experi
flow
cytometri
abl
convincingli
demonstr
cystein
proteas
inhibitor
cystatin
c
intern
five
cancer
cell
line
investig
studi
use
confoc
microscopi
western
blot
quantif
elisa
intern
cystein
inhibitor
verifi
delin
previous
target
enzym
cystein
proteas
inhibitor
shown
involv
cell
invas
metastasi
cancer
cystatin
also
propos
inhibit
viru
replic
cell
cultur
find
open
conceptu
new
line
research
order
elucid
extens
mechan
biolog
import
phenomenon
five
differ
human
cancer
cell
line
use
german
collect
cell
cultur
hamburg
germani
atcc
manassa
va
three
cell
line
human
breast
adenocarcinoma
epidermoid
carcinoma
human
pancrea
adenocarcinoma
cell
cultur
medium
use
dulbecco
modifi
eagl
medium
glucos
pyruv
supplement
fetal
calf
serum
penicillin
g
streptomycin
experi
amphotericin
b
invitrogen
grand
island
ny
usa
cell
lyse
naclpi
lysi
buffer
cell
lysat
cultur
medium
sampl
preserv
cocktail
ad
final
concentr
mm
benzamidinium
hydrochlorid
mm
mm
edta
recombin
human
cystatin
c
cystatin
c
amino
acid
substitut
c
cystatin
c
amino
acid
substitut
c
pci
fluoresc
label
alexa
fluor
protein
label
kit
molecular
probe
eugen
usa
equistatin
label
fluorescein
degre
protein
label
dol
estim
formula
recommend
manufactur
label
kit
dol
valu
cystatin
c
pci
cystatin
c
variant
c
c
exhibit
dol
valu
respect
dol
equistatin
estim
ms
bruker
spectromet
germani
cultur
plate
cell
seed
cultur
day
cell
incub
new
medium
contain
label
protein
control
cell
ad
equal
volum
naclpi
cell
incub
min
min
h
h
incub
cell
wash
three
time
naclpi
final
trypsin
minimum
min
cell
fluoresc
measur
fac
calibur
flow
cytomet
franklin
lake
nj
usa
least
event
measur
sampl
cell
gate
exclud
cell
debri
cell
conglomer
median
individu
cell
fluoresc
calcul
intern
cystatin
c
also
illustr
immunocytochemistri
cultur
plate
cell
seed
cover
slip
knittel
glasbearbeitung
gmbh
braunschweig
gemani
incub
day
reach
confluenc
cell
wash
twice
naclpi
new
cultur
medium
contain
recombin
cystatin
c
equival
volum
naclpi
ad
h
incub
cell
wash
naclpi
fix
methanolaceton
vv
paraformaldehyd
naclpi
nuclei
stain
either
propidium
iodid
sytoxgreen
control
experi
specif
test
perform
microscop
analys
cell
intern
molecular
probe
conjug
cystatin
c
unlabel
cystatin
c
detect
immunocytochemistri
control
experi
cellular
uptak
conjug
cystatin
c
cell
incub
unlabel
cystatin
c
follow
immunocytochem
detect
cystatin
c
intern
endogen
cystatin
c
visual
primari
antibodi
polyclon
rabbit
human
cystatin
c
serum
secondari
antibodi
use
made
goat
conjug
control
experi
includ
primari
antibodi
omiss
antigen
absorpt
incub
cystatin
c
conjug
cell
process
microscop
analys
label
gener
nuclear
marker
process
immunocytochemistri
label
cell
transfer
glass
slide
mount
coverslip
cell
initi
analys
microscop
olympu
ax
cystatin
c
secondari
antibodi
fluoresc
nuclear
marker
sytox
green
propidium
iodid
dapi
invitrogen
employ
imag
grab
digit
olympu
separ
individu
spectral
channel
merg
overlay
function
clsm
analys
perform
mrc
mount
invert
nikon
diaphot
microscop
anoth
clsm
zeiss
lsm
meta
microscop
use
case
excit
maxima
nm
conjunct
dapi
nuclear
marker
clsm
analys
set
optim
fluorophor
data
acquisit
obtain
sequenti
scan
individu
fluorophor
provid
total
separ
light
collect
channel
level
record
channel
cell
popul
use
background
signal
adjust
set
individu
channel
optic
slice
around
nm
collect
cell
cellular
local
presenc
within
cytoplasm
cystatin
c
conjug
analys
individu
optic
section
merg
imag
imag
analys
laser
sharp
zeiss
lsm
softwar
live
imag
experi
cell
seed
ibitreat
well
lri
instrument
ab
lund
sweden
incub
overnight
medium
chang
cystatin
ad
final
concentr
nm
min
cell
wash
naclpi
new
medium
contain
nm
lysotrack
molecular
probe
ad
live
cell
analys
invert
fluoresc
microscop
olympu
equip
larg
incub
thu
heat
environ
stabl
condit
apochromat
oil
immers
object
numer
apertur
use
pictur
grab
hamamatsu
orca
hamamatsu
photon
norden
ab
solna
sweden
monochromat
camera
cultur
plate
cell
seed
cultur
reach
confluenc
cultur
medium
chang
cell
incub
h
new
cultur
medium
secret
cystatin
c
determin
cultur
medium
cell
lyse
quantif
intracellular
cystatin
c
level
cystatin
c
concentr
cultur
medium
lysat
measur
use
elisa
describ
previous
cystatin
c
level
correl
protein
content
cell
lysat
determin
sampl
dilut
coomassi
protein
assay
reagent
pierc
rockford
il
usa
experi
carri
similar
manner
cell
incub
medium
contain
recombin
cystatin
c
determin
basal
cystatin
c
level
follow
measur
cellular
content
activ
cystein
proteas
inhibitor
cystatin
c
incub
manner
cell
seed
cultur
plate
cultur
reach
confluenc
cell
wash
twice
naclpi
new
cultur
medium
cystatin
c
equival
volum
naclpi
ad
cell
incub
min
h
harvest
cystatin
c
concentr
lysat
measur
elisa
describ
previous
level
cystatin
c
correl
protein
content
cell
lysat
determin
coomassi
protein
assay
reagent
cell
cultur
quantif
endogen
secret
cystatin
c
cell
wash
twice
naclpi
new
cultur
medium
cystatin
c
equival
volum
naclpi
ad
cell
incub
min
h
lysat
prepar
rather
low
cystatin
c
content
concentr
ten
microlitr
bead
amersham
bioscienc
uppsala
sweden
coupl
carboxymethyl
papain
sigma
aldrich
steinway
germani
ad
lysat
follow
h
incub
shaker
centrifug
supernat
discard
nupag
ld
sampl
buffer
nupag
sampl
reduc
agent
invitrogen
ad
remain
gel
pellet
protein
separ
sdspage
gel
novex
invitrogen
ab
stockholm
sweden
electroblot
poli
vinyliden
difluorid
membran
millipor
bedford
usa
blot
protein
immunodetect
use
polyclon
rabbit
human
cystatin
c
serum
secondari
antibodi
conjug
goat
rabbit
igg
fraction
dako
copenhagen
denmark
use
blot
protein
visual
chemiluminesc
ecl
plu
reagent
amersham
bioscienc
piscataway
nj
usa
control
two
sampl
contain
ng
cystatin
c
ad
separ
gel
band
quantifi
use
nih
imag
softwar
nih
bethesda
md
usa
epson
express
scanner
activ
papain
use
sigma
aldrich
determin
titrat
irrevers
cystein
proteas
inhibitor
sigma
aldrich
bachem
bubendorf
switzerland
use
substrat
buffer
mix
final
concentr
phosphat
ph
mm
dithiothreitol
mm
edta
contain
papain
ad
final
volum
adjust
sigma
aldrich
mixtur
allow
incub
min
addit
substrat
fluoresc
measur
plate
reader
fluoroskan
ascent
thermo
electron
vantaa
finland
nm
excit
nm
emiss
differ
fluoresc
start
follow
min
incub
sampl
reflect
remain
enzym
activ
concentr
compar
sampl
without
ad
use
construct
titrat
curv
cystein
proteas
inhibitori
capac
cell
lysat
determin
measur
inhibit
papain
well
cathepsin
b
measur
capac
cell
lysat
inhibit
papain
buffer
mix
contain
papain
use
cell
lysat
ad
mixtur
allow
incub
min
addit
substrat
posit
neg
control
instead
cell
lysat
use
respect
fluoresc
measur
plate
reader
start
end
incub
measur
inhibit
cathepsin
b
kindli
provid
j
mort
shriner
hospit
montreal
quebec
canada
buffer
mix
contain
cathepsin
b
nm
cell
lysat
use
posit
neg
control
instead
cell
lysat
use
mixtur
allow
incub
min
addit
substrat
cell
seed
grown
treat
except
unlabel
cystatin
c
ad
addit
cystatin
c
cell
incub
h
cell
fluoresc
measur
fac
calibur
flow
cytomet
median
individu
cell
fluoresc
calcul
result
relat
fluoresc
cell
incub
without
compet
unlabel
inhibitor
